Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7351-7360 of 13156

Page
per page
  1. Nintedanib esylate
    C6370 Nintedanib esylate
      ≥26.15 mg/mL
  2. Cerdulatinib (PRT062070)
    B8023 Cerdulatinib (PRT062070)
    Target: JAK|Syk|TYK2
    Summary: Syk/JAK inhibitor
      ≥22.3 mg/mL
  3. RG 13022
    B6115 RG 13022
    Summary: EGFR tyrosine kinase inhibitor
      ≥26.6 mg/mL
  4. 17-Hydroxyprogesterone
    B6126 17-Hydroxyprogesterone
    Summary: endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones
  5. Perphenazine
    B6157 Perphenazine
     1 Citation
    Summary: A dopamine antagonist
  6. O-1821
    C3631 O-1821
    Summary: cannabidiol analog with close structural similarity to O-1918 which is a selective antagonist of abnormal cannabidiol
      ≤30 mg/mL
  7. Bisindolylmaleimide VIII (acetate)
    C4315 Bisindolylmaleimide VIII (acetate)
    Summary: protein kinase C (PKC) inhibitor
      Soluble in DMSO
  8. CP-465022 (maleate)
    C4398 CP-465022 (maleate)
    Summary: AMPA antagonist
      Soluble in DMSO
  9. Aceclidine (hydrochloride)
    C4635 Aceclidine (hydrochloride)
    Summary: agonist of muscarinic receptors
      ≤30 mg/mL
  10. Cetaben
    C5151 Cetaben
    Summary: unique,PPARα-independent peroxisome proliferator
      ≤1 mg/mL

Items 7351-7360 of 13156

Page
per page